European Parliament and Committee on the Environment, Climate and Food Safety 10 October 2019, European Parliament resolution of 10 October 2019 on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (2019/2825(RSP))

Also known as

European Union · · · Cited by 2 · 10-10-2019

28.5.2021 EN Official Journal of the European Union C 202/2 P9_TA(2019)0026 Active substances, including flumioxazine European Parliament resolution of 10 October 2019 on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid,

Read the full text

This document is published by eur-lex.europa.eu.

Moonlit adds the citation network (2 references), article-level links and cross-references, which are available to search for free.